Literature DB >> 1979093

Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users.

P Simmonds1, L Q Zhang, H G Watson, S Rebus, E D Ferguson, P Balfe, G H Leadbetter, P L Yap, J F Peutherer, C A Ludlam.   

Abstract

The polymerase chain reaction (PCR) detected specific hepatitis C viral (HCV) RNA sequences in plasma from 15 of 21 haemophiliacs (12 HCV-antibody positive) and 7 of 27 intravenous drug users (13 HCV-antibody positive). Quantification of RNA-positive samples showed high levels of HCV (10(5) to 10(6) copies of RNA/ml) in infected patients. HCV was more frequently found in haemophiliacs infected with human immunodeficiency virus (11/11 HIV-positive and 4/10 HIV-negative patients). HCV-RNA was detected in all batches of commercially available factor VIII tested and in low concentrations in some pools of plasma donations from volunteers. Factor VIII, manufactured from volunteer donations, was uniformly negative by PCR. Phylogenetic analysis of viral sequences showed two distinct groups: one was associated with intravenous drug users and the other with haemophiliacs infected with Scottish factor VIII preparations. Both were distinct from sequences found in commercially available factor VIII.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1979093     DOI: 10.1016/0140-6736(90)93179-s

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  37 in total

1.  A flexible bioluminescent-quantitative polymerase chain reaction assay for analysis of competitive PCR amplicons.

Authors:  J K Actor; J R Limor; R L Hunter
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

2.  Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus.

Authors:  J T Wang; T H Wang; J C Sheu; S M Lin; J T Lin; D S Chen
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

3.  Development and validation of a rotor-gene real-time PCR assay for detection, identification, and quantification of Chlamydia trachomatis in a single reaction.

Authors:  Hamid Jalal; Hannah Stephen; Martin D Curran; Janet Burton; Michelle Bradley; Christopher Carne
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

4.  Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C.

Authors:  A Sánchez-Quijano; J Andreu; F Gavilán; F Luque; M A Abad; B Soto; J Muñoz; J M Aznar; M Leal; E Lissen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-11       Impact factor: 3.267

5.  Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C.

Authors:  T L Fong; M Shindo; S M Feinstone; J H Hoofnagle; A M Di Bisceglie
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

6.  Evaluation of third-generation assays for detection of anti-hepatitis C virus (HCV) antibodies and comparison with presence of HCV RNA in blood donors reactive to c100-3 antigen.

Authors:  D Lavanchy; C Mayerat; B Morel; P Schneider; C Zufferey; J J Gonvers; A Pécoud; P C Frei
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

7.  Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations.

Authors:  M François; F Dubois; D Brand; Y Bacq; C Guerois; C Mouchet; J Tichet; A Goudeau; F Barin
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

8.  Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.

Authors:  P Simmonds; K A Rose; S Graham; S W Chan; F McOmish; B C Dow; E A Follett; P L Yap; H Marsden
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

9.  Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein.

Authors:  Ania Owsianka; Alexander W Tarr; Vicky S Juttla; Dimitri Lavillette; Birke Bartosch; François-Loïc Cosset; Jonathan K Ball; Arvind H Patel
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 10.  Viral markers in the treatment of hepatitis B and C.

Authors:  H Schmilovitz-Weiss; M Levy; N Thompson; G Dusheiko
Journal:  Gut       Date:  1993       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.